| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modification-dependent protein binding | 9.84e-07 | 206 | 33 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.51e-06 | 753 | 33 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | p53 binding | 7.68e-06 | 77 | 33 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.62e-05 | 30 | 33 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.79e-05 | 31 | 33 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.07e-05 | 739 | 33 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.47e-05 | 229 | 33 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.38e-04 | 14 | 33 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 4.76e-04 | 875 | 33 | 7 | GO:0019904 | |
| GeneOntologyMolecularFunction | DNA binding, bending | 4.94e-04 | 20 | 33 | 2 | GO:0008301 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 5.68e-04 | 417 | 33 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 6.56e-04 | 23 | 33 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 8.79e-04 | 262 | 33 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone binding | 9.17e-04 | 265 | 33 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.19e-03 | 127 | 33 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.39e-03 | 134 | 33 | 3 | GO:0003697 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.50e-03 | 303 | 33 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.58e-03 | 140 | 33 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.70e-03 | 37 | 33 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.14e-03 | 562 | 33 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | helicase activity | 2.23e-03 | 158 | 33 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.50e-03 | 582 | 33 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.61e-03 | 167 | 33 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor activity | 3.34e-03 | 52 | 33 | 2 | GO:0016251 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.59e-03 | 187 | 33 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 3.72e-03 | 55 | 33 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 4.71e-03 | 62 | 33 | 2 | GO:0003678 | |
| GeneOntologyMolecularFunction | general transcription initiation factor activity | 5.64e-03 | 68 | 33 | 2 | GO:0140223 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.79e-03 | 441 | 33 | 4 | GO:0016887 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 5.87e-03 | 1356 | 33 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 8.29e-03 | 83 | 33 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 8.69e-03 | 1459 | 33 | 7 | GO:0000977 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 9.28e-03 | 88 | 33 | 2 | GO:0140034 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.09e-02 | 1160 | 33 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 1.45e-02 | 111 | 33 | 2 | GO:0003727 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.50e-02 | 1244 | 33 | 6 | GO:0000978 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SMARCA4 GON4L CHD8 METTL13 TAF3 RARG MED1 TCERG1 MEIS2 FOXC1 OTUD7B BRD7 | 8.42e-07 | 1399 | 33 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SMARCA4 GON4L CHD8 METTL13 TAF3 RARG MED1 TCERG1 MEIS2 FOXC1 OTUD7B BRD7 | 9.36e-07 | 1413 | 33 | 12 | GO:1902679 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.05e-06 | 917 | 33 | 10 | GO:0016071 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SMARCA4 CHD8 METTL13 TAF3 RARG MED1 TCERG1 MEIS2 FOXC1 OTUD7B | 3.64e-06 | 1053 | 33 | 10 | GO:0000122 |
| GeneOntologyBiologicalProcess | transcription preinitiation complex assembly | 1.00e-05 | 85 | 33 | 4 | GO:0070897 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 1.09e-05 | 186 | 33 | 5 | GO:0006367 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.90e-05 | 999 | 33 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | mRNA processing | 2.18e-05 | 551 | 33 | 7 | GO:0006397 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 2.36e-05 | 35 | 33 | 3 | GO:0035116 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 3.10e-05 | 231 | 33 | 5 | GO:0006352 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 3.61e-05 | 596 | 33 | 7 | GO:0001701 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 4.10e-05 | 42 | 33 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 4.13e-05 | 1390 | 33 | 10 | GO:0045944 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 4.43e-05 | 249 | 33 | 5 | GO:0065004 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 4.73e-05 | 44 | 33 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 4.88e-05 | 127 | 33 | 4 | GO:0006368 | |
| GeneOntologyBiologicalProcess | embryo development | 5.48e-05 | 1437 | 33 | 10 | GO:0009790 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 6.54e-05 | 49 | 33 | 3 | GO:0035137 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 7.00e-05 | 906 | 33 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 7.97e-05 | 144 | 33 | 4 | GO:0006354 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 8.35e-05 | 929 | 33 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 1.14e-04 | 1256 | 33 | 9 | GO:0051726 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.28e-04 | 502 | 33 | 6 | GO:0008380 | |
| GeneOntologyBiologicalProcess | RNA polymerase II preinitiation complex assembly | 1.98e-04 | 71 | 33 | 3 | GO:0051123 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | 2.38e-04 | 1081 | 33 | 8 | GO:0006259 | |
| GeneOntologyBiologicalProcess | cell cycle process | 3.21e-04 | 1441 | 33 | 9 | GO:0022402 | |
| GeneOntologyBiologicalProcess | microtubule-based protein transport | 3.33e-04 | 17 | 33 | 2 | GO:0099118 | |
| GeneOntologyBiologicalProcess | protein transport along microtubule | 3.33e-04 | 17 | 33 | 2 | GO:0098840 | |
| GeneOntologyBiologicalProcess | positive regulation of keratinocyte differentiation | 4.17e-04 | 19 | 33 | 2 | GO:0045618 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 4.39e-04 | 93 | 33 | 3 | GO:0034243 | |
| GeneOntologyBiologicalProcess | DNA conformation change | 4.53e-04 | 94 | 33 | 3 | GO:0071103 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 6.26e-04 | 105 | 33 | 3 | GO:0032784 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 8.76e-04 | 720 | 33 | 6 | GO:0000226 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermal cell differentiation | 9.14e-04 | 28 | 33 | 2 | GO:0045606 | |
| GeneOntologyBiologicalProcess | eye development | 9.26e-04 | 480 | 33 | 5 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 9.52e-04 | 483 | 33 | 5 | GO:0150063 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 9.81e-04 | 29 | 33 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.02e-03 | 741 | 33 | 6 | GO:0006338 | |
| GeneOntologyBiologicalProcess | sensory system development | 1.02e-03 | 491 | 33 | 5 | GO:0048880 | |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 1.19e-03 | 32 | 33 | 2 | GO:0035162 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 1.27e-03 | 33 | 33 | 2 | GO:0045684 | |
| GeneOntologyBiologicalProcess | centrosome localization | 1.43e-03 | 35 | 33 | 2 | GO:0051642 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.49e-03 | 312 | 33 | 4 | GO:0006260 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 1.51e-03 | 36 | 33 | 2 | GO:0061842 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 1.56e-03 | 540 | 33 | 5 | GO:1903706 | |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 1.68e-03 | 38 | 33 | 2 | GO:0061384 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 1.69e-03 | 148 | 33 | 3 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 1.69e-03 | 148 | 33 | 3 | GO:0035113 | |
| GeneOntologyBiologicalProcess | gland development | 1.80e-03 | 558 | 33 | 5 | GO:0048732 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.85e-03 | 561 | 33 | 5 | GO:0048568 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte differentiation | 1.86e-03 | 40 | 33 | 2 | GO:0045616 | |
| GeneOntologyBiologicalProcess | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.05e-03 | 42 | 33 | 2 | GO:0032435 | |
| GeneOntologyBiologicalProcess | RNA processing | 2.06e-03 | 1500 | 33 | 8 | GO:0006396 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 2.14e-03 | 161 | 33 | 3 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 2.14e-03 | 161 | 33 | 3 | GO:0003231 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 2.37e-03 | 594 | 33 | 5 | GO:0007346 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 2.46e-03 | 46 | 33 | 2 | GO:0009303 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 2.55e-03 | 362 | 33 | 4 | GO:0034504 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell differentiation | 2.57e-03 | 47 | 33 | 2 | GO:0060218 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.68e-03 | 896 | 33 | 6 | GO:0006325 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 2.78e-03 | 1223 | 33 | 7 | GO:0030097 | |
| GeneOntologyBiologicalProcess | cellular response to epidermal growth factor stimulus | 2.79e-03 | 49 | 33 | 2 | GO:0071364 | |
| GeneOntologyBiologicalProcess | nuclear transport | 2.98e-03 | 378 | 33 | 4 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 2.98e-03 | 378 | 33 | 4 | GO:0006913 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 3.01e-03 | 51 | 33 | 2 | GO:1902459 | |
| GeneOntologyBiologicalProcess | head development | 3.04e-03 | 919 | 33 | 6 | GO:0060322 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 3.13e-03 | 52 | 33 | 2 | GO:0042789 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA binding | 3.13e-03 | 52 | 33 | 2 | GO:0043388 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.18e-03 | 185 | 33 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.18e-03 | 185 | 33 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 3.37e-03 | 54 | 33 | 2 | GO:0032968 | |
| GeneOntologyBiologicalProcess | response to epidermal growth factor | 3.37e-03 | 54 | 33 | 2 | GO:0070849 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 3.37e-03 | 54 | 33 | 2 | GO:0045663 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 3.37e-03 | 189 | 33 | 3 | GO:0030216 | |
| GeneOntologyBiologicalProcess | DNA repair | 3.45e-03 | 648 | 33 | 5 | GO:0006281 | |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | 3.52e-03 | 651 | 33 | 5 | GO:0019941 | |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | 3.64e-03 | 656 | 33 | 5 | GO:0043632 | |
| GeneOntologyBiologicalProcess | DNA damage response | 3.75e-03 | 959 | 33 | 6 | GO:0006974 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 3.75e-03 | 57 | 33 | 2 | GO:0009299 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 3.75e-03 | 57 | 33 | 2 | GO:0061383 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SMARCA4 GON4L CHD8 GTF2F2 TAF3 SREK1 CDC5L MED1 THOC2 UPF2 INTS13 DDX11L8 BRD9 BRD7 | 1.69e-08 | 1377 | 35 | 14 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | SMARCA4 GON4L CHD8 RARG MED1 PHF20L1 DDX11L8 MEIS2 CHAF1A FOXC1 BRD9 BRD7 | 2.73e-06 | 1480 | 35 | 12 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear speck | 6.16e-06 | 431 | 35 | 7 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | 1.29e-05 | 903 | 35 | 9 | GO:0016604 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.96e-05 | 96 | 35 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | dendritic branch | 5.69e-05 | 7 | 35 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | ATPase complex | 6.25e-05 | 129 | 35 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | GBAF complex | 2.45e-04 | 14 | 35 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | RSC-type complex | 2.82e-04 | 15 | 35 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 4.00e-04 | 86 | 35 | 3 | GO:0001673 | |
| GeneOntologyCellularComponent | nuclear chromosome | 8.29e-04 | 254 | 35 | 4 | GO:0000228 | |
| GeneOntologyCellularComponent | germ cell nucleus | 8.87e-04 | 113 | 35 | 3 | GO:0043073 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.15e-03 | 30 | 35 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.64e-03 | 140 | 35 | 3 | GO:0016363 | |
| GeneOntologyCellularComponent | fibrillar center | 2.24e-03 | 156 | 35 | 3 | GO:0001650 | |
| GeneOntologyCellularComponent | nuclear periphery | 2.90e-03 | 171 | 35 | 3 | GO:0034399 | |
| MousePheno | embryonic lethality prior to tooth bud stage, incomplete penetrance | 4.53e-05 | 97 | 29 | 4 | MP:0014258 | |
| MousePheno | embryonic lethality prior to organogenesis, incomplete penetrance | 4.53e-05 | 97 | 29 | 4 | MP:0014260 | |
| MousePheno | embryonic lethality prior to organogenesis | 9.44e-05 | 1204 | 29 | 10 | MP:0013292 | |
| MousePheno | abnormal head size | 1.88e-04 | 140 | 29 | 4 | MP:0011496 | |
| MousePheno | abnormal apoptosis | SMARCA4 CHD8 MED1 THOC2 RBBP6 DDX11L8 MEIS2 FOXC1 OTUD7B BRD7 | 2.50e-04 | 1353 | 29 | 10 | MP:0001648 |
| MousePheno | abnormal exocrine gland morphology | 2.53e-04 | 853 | 29 | 8 | MP:0013558 | |
| MousePheno | abnormal programmed cell death | SMARCA4 CHD8 MED1 THOC2 RBBP6 DDX11L8 MEIS2 FOXC1 OTUD7B BRD7 | 2.61e-04 | 1360 | 29 | 10 | MP:0014355 |
| MousePheno | impaired spatial working memory | 2.71e-04 | 12 | 29 | 2 | MP:0014370 | |
| MousePheno | embryonic lethality prior to tooth bud stage | 2.99e-04 | 1383 | 29 | 10 | MP:0013293 | |
| MousePheno | patent ductus arteriosus | 3.20e-04 | 13 | 29 | 2 | MP:0003139 | |
| MousePheno | abnormal cricoid cartilage morphology | 4.29e-04 | 15 | 29 | 2 | MP:0002258 | |
| Domain | DUF3512 | 3.03e-06 | 2 | 33 | 2 | PF12024 | |
| Domain | DUF3512 | 3.03e-06 | 2 | 33 | 2 | IPR021900 | |
| Domain | BROMODOMAIN_1 | 3.75e-05 | 37 | 33 | 3 | PS00633 | |
| Domain | Bromodomain | 4.06e-05 | 38 | 33 | 3 | PF00439 | |
| Domain | BRK | 4.52e-05 | 6 | 33 | 2 | SM00592 | |
| Domain | BRK_domain | 4.52e-05 | 6 | 33 | 2 | IPR006576 | |
| Domain | BRK | 4.52e-05 | 6 | 33 | 2 | PF07533 | |
| Domain | BROMODOMAIN_2 | 5.12e-05 | 41 | 33 | 3 | PS50014 | |
| Domain | BROMO | 5.50e-05 | 42 | 33 | 3 | SM00297 | |
| Domain | Bromodomain | 5.50e-05 | 42 | 33 | 3 | IPR001487 | |
| Domain | - | 5.50e-05 | 42 | 33 | 3 | 1.20.920.10 | |
| Domain | Zinc_finger_PHD-type_CS | 2.04e-04 | 65 | 33 | 3 | IPR019786 | |
| Domain | ZF_PHD_1 | 6.42e-04 | 96 | 33 | 3 | PS01359 | |
| Domain | SNF2_N | 1.45e-03 | 32 | 33 | 2 | PF00176 | |
| Domain | SNF2_N | 1.45e-03 | 32 | 33 | 2 | IPR000330 | |
| Domain | MYB_LIKE | 2.05e-03 | 38 | 33 | 2 | PS50090 | |
| Domain | Znf_FYVE_PHD | 2.19e-03 | 147 | 33 | 3 | IPR011011 | |
| Domain | SANT | 3.52e-03 | 50 | 33 | 2 | SM00717 | |
| Domain | SANT/Myb | 3.80e-03 | 52 | 33 | 2 | IPR001005 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.73e-06 | 22 | 23 | 3 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.51e-06 | 24 | 23 | 3 | M13404 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.72e-05 | 1022 | 23 | 9 | MM15436 | |
| Pathway | PID_RXR_VDR_PATHWAY | 8.08e-04 | 26 | 23 | 2 | M162 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 9.62e-04 | 277 | 23 | 4 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.04e-03 | 283 | 23 | 4 | M13087 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 1.09e-03 | 1387 | 23 | 8 | M734 | |
| Pathway | KEGG_SPLICEOSOME | 1.11e-03 | 127 | 23 | 3 | M2044 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.16e-03 | 768 | 23 | 6 | MM14851 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SMARCA4 CHD8 GTF2F2 TAF3 SREK1 CDC5L MED1 THOC2 TCERG1 RBBP6 PHF3 TOP1 CHAF1A FOXC1 SON BRD9 BRD7 | 6.99e-18 | 954 | 35 | 17 | 36373674 |
| Pubmed | SMARCA4 CHD8 LONP1 GTF2F2 TAF3 CDC5L MED1 THOC2 TCERG1 RBBP6 PHF3 INTS13 TOP1 CHAF1A SON BRD9 | 5.86e-16 | 1014 | 35 | 16 | 32416067 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RABL6 SMARCA4 CHD8 LONP1 METTL13 TAF3 SREK1 CDC5L THOC2 UPF2 TCERG1 RBBP6 TOP1 CHAF1A RSRC1 SON BRD9 | 1.47e-15 | 1318 | 35 | 17 | 30463901 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SMARCA4 CHD8 GTF2F2 TAF3 MED1 PHF20L1 PHF3 TOP1 CHAF1A FOXC1 BRD9 BRD7 | 4.23e-13 | 608 | 35 | 12 | 36089195 |
| Pubmed | SMARCA4 CHD8 METTL13 TAF3 SREK1 MAP1A RBBP6 INTS13 TOP1 CHAF1A FOXC1 SON BRD9 BRD7 | 1.40e-12 | 1116 | 35 | 14 | 31753913 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | SMARCA4 CHD8 GTF2F2 TAF3 MED1 THOC2 TCERG1 INTS13 TOP1 CHAF1A BRD9 | 2.96e-12 | 533 | 35 | 11 | 30554943 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 6.72e-12 | 411 | 35 | 10 | 35182466 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.08e-12 | 283 | 35 | 9 | 30585729 | |
| Pubmed | GON4L CHD8 GTF2F2 SREK1 MED1 TCERG1 RBBP6 PHF3 INTS13 CHAF1A RSRC1 SON BRD9 BRD7 | 7.00e-11 | 1497 | 35 | 14 | 31527615 | |
| Pubmed | 1.14e-10 | 549 | 35 | 10 | 38280479 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SMARCA4 CDC5L MED1 THOC2 TCERG1 RBBP6 PHF3 INTS13 TOP1 CHAF1A RSRC1 FOXC1 SON | 1.70e-10 | 1294 | 35 | 13 | 30804502 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SMARCA4 TAF3 SREK1 CDC5L MED1 MAP1A THOC2 UPF2 TCERG1 RBBP6 TOP1 SON | 3.34e-10 | 1082 | 35 | 12 | 38697112 |
| Pubmed | SMARCA4 METTL13 TAF3 MED1 AKAP9 THOC2 UPF2 TCERG1 PHF3 TOP1 RSRC1 SON BRD7 | 3.45e-10 | 1371 | 35 | 13 | 36244648 | |
| Pubmed | SMARCA4 SREK1 CDC5L THOC2 TCERG1 RBBP6 PHF3 TOP1 RSRC1 FOXC1 SON | 4.10e-10 | 847 | 35 | 11 | 35850772 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.59e-09 | 759 | 35 | 10 | 35915203 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 4.33e-09 | 134 | 35 | 6 | 25452129 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 4.71e-09 | 583 | 35 | 9 | 29844126 | |
| Pubmed | SMARCA4 GON4L CHD8 LONP1 TAF3 TCERG1 RBBP6 TOP1 RSRC1 FOXC1 BRD9 BRD7 | 7.67e-09 | 1429 | 35 | 12 | 35140242 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 8.52e-09 | 150 | 35 | 6 | 28242625 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.86e-08 | 934 | 35 | 10 | 33916271 | |
| Pubmed | 3.60e-08 | 191 | 35 | 6 | 20195357 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.38e-08 | 774 | 35 | 9 | 15302935 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 9.27e-08 | 582 | 35 | 8 | 20467437 | |
| Pubmed | 1.27e-07 | 399 | 35 | 7 | 35987950 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.60e-07 | 444 | 35 | 7 | 34795231 | |
| Pubmed | 2.66e-07 | 268 | 35 | 6 | 33640491 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.84e-07 | 271 | 35 | 6 | 32433965 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 3.01e-07 | 949 | 35 | 9 | 36574265 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.57e-07 | 695 | 35 | 8 | 23602568 | |
| Pubmed | 3.76e-07 | 469 | 35 | 7 | 27634302 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 3.81e-07 | 701 | 35 | 8 | 30196744 | |
| Pubmed | 3.93e-07 | 472 | 35 | 7 | 38943005 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 4.26e-07 | 989 | 35 | 9 | 36424410 | |
| Pubmed | 4.33e-07 | 713 | 35 | 8 | 29802200 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 4.78e-07 | 486 | 35 | 7 | 30940648 | |
| Pubmed | 6.01e-07 | 503 | 35 | 7 | 16964243 | ||
| Pubmed | 6.26e-07 | 506 | 35 | 7 | 30890647 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 36484504 | ||
| Pubmed | 9.93e-07 | 75 | 35 | 4 | 25593309 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.09e-06 | 341 | 35 | 6 | 32971831 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.28e-06 | 351 | 35 | 6 | 38297188 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.74e-06 | 370 | 35 | 6 | 22922362 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.80e-06 | 87 | 35 | 4 | 17148452 | |
| Pubmed | 2.11e-06 | 25 | 35 | 3 | 15456888 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 3.09e-06 | 1257 | 35 | 9 | 36526897 | |
| Pubmed | 3.35e-06 | 29 | 35 | 3 | 19279220 | ||
| Pubmed | 3.39e-06 | 653 | 35 | 7 | 22586326 | ||
| Pubmed | 3.72e-06 | 30 | 35 | 3 | 31043422 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 4.34e-06 | 678 | 35 | 7 | 30209976 | |
| Pubmed | 4.78e-06 | 441 | 35 | 6 | 31239290 | ||
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 4.99e-06 | 33 | 35 | 3 | 33567268 | |
| Pubmed | 5.02e-06 | 250 | 35 | 5 | 33536335 | ||
| Pubmed | 5.12e-06 | 251 | 35 | 5 | 31076518 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 5.62e-06 | 1353 | 35 | 9 | 29467282 | |
| Pubmed | HMGA Interactome: new insights from phage display technology. | 5.90e-06 | 4 | 35 | 2 | 21417337 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 23541832 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 6.66e-06 | 724 | 35 | 7 | 36232890 | |
| Pubmed | 7.09e-06 | 731 | 35 | 7 | 29298432 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 8.53e-06 | 1425 | 35 | 9 | 30948266 | |
| Pubmed | USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy. | 9.82e-06 | 5 | 35 | 2 | 33257797 | |
| Pubmed | 1.10e-05 | 1103 | 35 | 8 | 34189442 | ||
| Pubmed | Genetic variations strongly influence phenotypic outcome in the mouse retina. | 1.38e-05 | 46 | 35 | 3 | 21779340 | |
| Pubmed | 1.88e-05 | 157 | 35 | 4 | 30186101 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.97e-05 | 332 | 35 | 5 | 32786267 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 20043900 | ||
| Pubmed | 2.18e-05 | 339 | 35 | 5 | 30415952 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 2.49e-05 | 56 | 35 | 3 | 26919559 | |
| Pubmed | 2.63e-05 | 57 | 35 | 3 | 21555454 | ||
| Pubmed | 2.65e-05 | 1247 | 35 | 8 | 27684187 | ||
| Pubmed | CHD7 cooperates with PBAF to control multipotent neural crest formation. | 2.74e-05 | 8 | 35 | 2 | 20130577 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 32640256 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.95e-05 | 361 | 35 | 5 | 26167880 | |
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 30355451 | ||
| Pubmed | The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA. | 3.53e-05 | 9 | 35 | 2 | 33524014 | |
| Pubmed | 3.84e-05 | 638 | 35 | 6 | 33239621 | ||
| Pubmed | 4.12e-05 | 1327 | 35 | 8 | 32694731 | ||
| Pubmed | 4.33e-05 | 652 | 35 | 6 | 31180492 | ||
| Pubmed | 4.38e-05 | 195 | 35 | 4 | 19454010 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.46e-05 | 394 | 35 | 5 | 27248496 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 4.67e-05 | 69 | 35 | 3 | 28481362 | |
| Pubmed | Reduced BMP4 abundance in Gata2 hypomorphic mutant mice result in uropathies resembling human CAKUT. | 5.38e-05 | 11 | 35 | 2 | 18233958 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.39e-05 | 410 | 35 | 5 | 26949251 | |
| Pubmed | 5.42e-05 | 206 | 35 | 4 | 34185411 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 5.63e-05 | 208 | 35 | 4 | 33230847 | |
| Pubmed | 5.84e-05 | 417 | 35 | 5 | 36537216 | ||
| Pubmed | 5.88e-05 | 689 | 35 | 6 | 36543142 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 6.14e-05 | 1024 | 35 | 7 | 24711643 | |
| Pubmed | 6.24e-05 | 76 | 35 | 3 | 22323595 | ||
| Pubmed | 6.24e-05 | 76 | 35 | 3 | 27542412 | ||
| Pubmed | 6.40e-05 | 215 | 35 | 4 | 30462309 | ||
| Pubmed | 6.40e-05 | 215 | 35 | 4 | 35973513 | ||
| Pubmed | A novel SR-related protein is required for the second step of Pre-mRNA splicing. | 6.45e-05 | 12 | 35 | 2 | 15798186 | |
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 18391015 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 6.49e-05 | 1415 | 35 | 8 | 28515276 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 6.63e-05 | 704 | 35 | 6 | 29955894 | |
| Pubmed | 6.74e-05 | 78 | 35 | 3 | 28611094 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 7.52e-05 | 440 | 35 | 5 | 34244565 | |
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 29920279 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 15882967 | ||
| Pubmed | 7.63e-05 | 225 | 35 | 4 | 12168954 | ||
| Interaction | BRD3 interactions | SMARCA4 CHD8 GTF2F2 TAF3 SREK1 MED1 THOC2 TCERG1 RBBP6 TOP1 CHAF1A SON BRD9 BRD7 | 3.41e-14 | 494 | 35 | 14 | int:BRD3 |
| Interaction | SMC5 interactions | SMARCA4 CHD8 GTF2F2 TAF3 SREK1 CDC5L MED1 THOC2 TCERG1 RBBP6 PHF3 TOP1 CHAF1A FOXC1 SON BRD9 BRD7 | 1.14e-13 | 1000 | 35 | 17 | int:SMC5 |
| Interaction | NR2C2 interactions | RABL6 SMARCA4 CHD8 LONP1 METTL13 TAF3 SREK1 CDC5L THOC2 UPF2 TCERG1 RBBP6 TOP1 CHAF1A RSRC1 SON BRD9 | 2.62e-11 | 1403 | 35 | 17 | int:NR2C2 |
| Interaction | DDX23 interactions | GTF2F2 TAF3 SREK1 CDC5L THOC2 TCERG1 RBBP6 PHF3 TOP1 RSRC1 FOXC1 | 3.11e-10 | 480 | 35 | 11 | int:DDX23 |
| Interaction | SSRP1 interactions | SMARCA4 SREK1 TCERG1 RBBP6 PHF3 INTS13 TOP1 CHAF1A RSRC1 FOXC1 SON BRD7 | 8.80e-10 | 685 | 35 | 12 | int:SSRP1 |
| Interaction | TERF2IP interactions | SMARCA4 CHD8 SREK1 MED1 THOC2 TCERG1 RBBP6 PHF3 TOP1 CHAF1A FOXC1 | 1.36e-09 | 552 | 35 | 11 | int:TERF2IP |
| Interaction | BRD2 interactions | 1.96e-09 | 429 | 35 | 10 | int:BRD2 | |
| Interaction | H3-3A interactions | SMARCA4 CHD8 GTF2F2 TAF3 MED1 PHF20L1 PHF3 TOP1 CHAF1A FOXC1 BRD9 BRD7 | 2.42e-09 | 749 | 35 | 12 | int:H3-3A |
| Interaction | PRPF40A interactions | 2.85e-09 | 446 | 35 | 10 | int:PRPF40A | |
| Interaction | SNRNP40 interactions | SMARCA4 GON4L SREK1 CDC5L PHF20L1 TCERG1 RBBP6 TOP1 RSRC1 FOXC1 SON | 6.04e-09 | 637 | 35 | 11 | int:SNRNP40 |
| Interaction | SMARCC2 interactions | 6.63e-09 | 353 | 35 | 9 | int:SMARCC2 | |
| Interaction | SUZ12 interactions | SMARCA4 CHD8 TAF3 RARG CDC5L AKAP9 THOC2 TOP1 CHAF1A SON BRD7 | 6.76e-09 | 644 | 35 | 11 | int:SUZ12 |
| Interaction | MEN1 interactions | SMARCA4 CHD8 GTF2F2 SREK1 MED1 PHF20L1 THOC2 UPF2 TCERG1 RBBP6 TOP1 FOXC1 SON | 7.68e-09 | 1029 | 35 | 13 | int:MEN1 |
| Interaction | H3C3 interactions | 7.72e-09 | 495 | 35 | 10 | int:H3C3 | |
| Interaction | ARID1A interactions | 1.91e-08 | 276 | 35 | 8 | int:ARID1A | |
| Interaction | GATA4 interactions | 2.47e-08 | 411 | 35 | 9 | int:GATA4 | |
| Interaction | XRCC6 interactions | SMARCA4 CHD8 GTF2F2 MED1 THOC2 TCERG1 RBBP6 PHF3 INTS13 TOP1 CHAF1A BRD7 | 2.65e-08 | 928 | 35 | 12 | int:XRCC6 |
| Interaction | HMGA1 interactions | 2.91e-08 | 419 | 35 | 9 | int:HMGA1 | |
| Interaction | H2BC8 interactions | SMARCA4 GON4L CHD8 GTF2F2 TCERG1 PHF3 TOP1 CHAF1A FOXC1 BRD7 | 3.24e-08 | 576 | 35 | 10 | int:H2BC8 |
| Interaction | CIT interactions | SMARCA4 CHD8 LONP1 SREK1 CDC5L MED1 AKAP9 SPAG17 THOC2 TCERG1 RBBP6 TOP1 CHAF1A SON | 5.16e-08 | 1450 | 35 | 14 | int:CIT |
| Interaction | JMJD6 interactions | 5.37e-08 | 205 | 35 | 7 | int:JMJD6 | |
| Interaction | SMARCA4 interactions | 6.73e-08 | 462 | 35 | 9 | int:SMARCA4 | |
| Interaction | MECP2 interactions | SMARCA4 TAF3 SREK1 CDC5L MED1 MAP1A THOC2 UPF2 TCERG1 RBBP6 TOP1 FOXC1 SON | 1.09e-07 | 1287 | 35 | 13 | int:MECP2 |
| Interaction | ZCCHC10 interactions | 1.41e-07 | 236 | 35 | 7 | int:ZCCHC10 | |
| Interaction | YAP1 interactions | SMARCA4 CHD8 GTF2F2 TAF3 RARG MED1 THOC2 TCERG1 RBBP6 PHF3 FOXC1 OTUD7B | 1.62e-07 | 1095 | 35 | 12 | int:YAP1 |
| Interaction | LINC02370 interactions | 2.67e-07 | 8 | 35 | 3 | int:LINC02370 | |
| Interaction | NONO interactions | 2.90e-07 | 549 | 35 | 9 | int:NONO | |
| Interaction | SRSF1 interactions | 3.98e-07 | 570 | 35 | 9 | int:SRSF1 | |
| Interaction | SNRNP70 interactions | RABL6 SMARCA4 SREK1 CDC5L THOC2 UPF2 RBBP6 TOP1 RSRC1 FOXC1 SON | 5.03e-07 | 984 | 35 | 11 | int:SNRNP70 |
| Interaction | LINC02910 interactions | 6.07e-07 | 95 | 35 | 5 | int:LINC02910 | |
| Interaction | SNRPC interactions | 6.80e-07 | 440 | 35 | 8 | int:SNRPC | |
| Interaction | SAP18 interactions | 7.94e-07 | 305 | 35 | 7 | int:SAP18 | |
| Interaction | NUP43 interactions | 8.59e-07 | 625 | 35 | 9 | int:NUP43 | |
| Interaction | SMARCD3 interactions | 1.10e-06 | 107 | 35 | 5 | int:SMARCD3 | |
| Interaction | RBM25 interactions | 1.16e-06 | 323 | 35 | 7 | int:RBM25 | |
| Interaction | CDC5L interactions | 1.25e-06 | 855 | 35 | 10 | int:CDC5L | |
| Interaction | PRP4K interactions | 1.32e-06 | 329 | 35 | 7 | int:PRP4K | |
| Interaction | SNRPA interactions | 1.35e-06 | 482 | 35 | 8 | int:SNRPA | |
| Interaction | DHX9 interactions | 1.38e-06 | 662 | 35 | 9 | int:DHX9 | |
| Interaction | CIC interactions | 1.59e-06 | 673 | 35 | 9 | int:CIC | |
| Interaction | ACTC1 interactions | 2.04e-06 | 694 | 35 | 9 | int:ACTC1 | |
| Interaction | SNRPB interactions | 2.27e-06 | 517 | 35 | 8 | int:SNRPB | |
| Interaction | PML interactions | SMARCA4 CHD8 LONP1 GTF2F2 CDC5L MED1 MAP1A THOC2 TCERG1 PHF3 | 2.75e-06 | 933 | 35 | 10 | int:PML |
| Interaction | CENPA interactions | 3.25e-06 | 377 | 35 | 7 | int:CENPA | |
| Interaction | SMARCC1 interactions | 3.66e-06 | 384 | 35 | 7 | int:SMARCC1 | |
| Interaction | ASF1A interactions | 4.03e-06 | 249 | 35 | 6 | int:ASF1A | |
| Interaction | NAA40 interactions | 4.19e-06 | 978 | 35 | 10 | int:NAA40 | |
| Interaction | SFPQ interactions | 4.27e-06 | 563 | 35 | 8 | int:SFPQ | |
| Interaction | HECTD1 interactions | 4.42e-06 | 984 | 35 | 10 | int:HECTD1 | |
| Interaction | AR interactions | 4.75e-06 | 992 | 35 | 10 | int:AR | |
| Interaction | CEBPA interactions | SMARCA4 CHD8 GTF2F2 MED1 AKAP9 THOC2 TCERG1 INTS13 TOP1 FOXC1 BRD9 | 5.03e-06 | 1245 | 35 | 11 | int:CEBPA |
| Interaction | PRPF8 interactions | 5.09e-06 | 776 | 35 | 9 | int:PRPF8 | |
| Interaction | MSH6 interactions | 6.54e-06 | 271 | 35 | 6 | int:MSH6 | |
| Interaction | DOT1L interactions | 7.00e-06 | 807 | 35 | 9 | int:DOT1L | |
| Interaction | FOXP3 interactions | 7.93e-06 | 432 | 35 | 7 | int:FOXP3 | |
| Interaction | SUPT16H interactions | 9.20e-06 | 442 | 35 | 7 | int:SUPT16H | |
| Interaction | ZNF330 interactions | 9.76e-06 | 446 | 35 | 7 | int:ZNF330 | |
| Interaction | HNRNPC interactions | 1.02e-05 | 634 | 35 | 8 | int:HNRNPC | |
| Interaction | BRD7 interactions | 1.05e-05 | 637 | 35 | 8 | int:BRD7 | |
| Interaction | CPSF2 interactions | 1.16e-05 | 173 | 35 | 5 | int:CPSF2 | |
| Interaction | SRRM2 interactions | 1.23e-05 | 462 | 35 | 7 | int:SRRM2 | |
| Interaction | SP7 interactions | 1.26e-05 | 304 | 35 | 6 | int:SP7 | |
| Interaction | MYCN interactions | SMARCA4 CDC5L THOC2 UPF2 RBBP6 PHF3 TOP1 RSRC1 SON BRD9 BRD7 | 1.28e-05 | 1373 | 35 | 11 | int:MYCN |
| Interaction | SMARCD2 interactions | 1.52e-05 | 183 | 35 | 5 | int:SMARCD2 | |
| Interaction | POLR1G interactions | 1.77e-05 | 489 | 35 | 7 | int:POLR1G | |
| Interaction | SOX2 interactions | SMARCA4 CHD8 LONP1 MED1 PHF20L1 MAP1A TOP1 MEIS2 FOXC1 OTUD7B BRD7 | 1.78e-05 | 1422 | 35 | 11 | int:SOX2 |
| Interaction | TOP1 interactions | 2.00e-05 | 696 | 35 | 8 | int:TOP1 | |
| Interaction | H2BC21 interactions | 2.00e-05 | 696 | 35 | 8 | int:H2BC21 | |
| Interaction | GATA2 interactions | 2.28e-05 | 199 | 35 | 5 | int:GATA2 | |
| Interaction | SF3A3 interactions | 2.37e-05 | 340 | 35 | 6 | int:SF3A3 | |
| Interaction | NUP50 interactions | 2.41e-05 | 341 | 35 | 6 | int:NUP50 | |
| Interaction | NPM1 interactions | 2.54e-05 | 1201 | 35 | 10 | int:NPM1 | |
| Interaction | SMARCA2 interactions | 2.61e-05 | 346 | 35 | 6 | int:SMARCA2 | |
| Interaction | DPF2 interactions | 2.74e-05 | 349 | 35 | 6 | int:DPF2 | |
| Interaction | SMARCD1 interactions | 2.74e-05 | 349 | 35 | 6 | int:SMARCD1 | |
| Interaction | CPSF6 interactions | 2.83e-05 | 526 | 35 | 7 | int:CPSF6 | |
| Interaction | TNIP1 interactions | 2.84e-05 | 1217 | 35 | 10 | int:TNIP1 | |
| Interaction | THOC1 interactions | 2.95e-05 | 210 | 35 | 5 | int:THOC1 | |
| Interaction | SMARCB1 interactions | 3.47e-05 | 364 | 35 | 6 | int:SMARCB1 | |
| Interaction | PAX6 interactions | 3.58e-05 | 366 | 35 | 6 | int:PAX6 | |
| Interaction | H2AZ1 interactions | 3.86e-05 | 371 | 35 | 6 | int:H2AZ1 | |
| Interaction | TNIK interactions | 4.48e-05 | 381 | 35 | 6 | int:TNIK | |
| Interaction | BUB3 interactions | 4.74e-05 | 232 | 35 | 5 | int:BUB3 | |
| Interaction | SF3B1 interactions | 4.77e-05 | 571 | 35 | 7 | int:SF3B1 | |
| Interaction | PARP1 interactions | 5.54e-05 | 1316 | 35 | 10 | int:PARP1 | |
| Interaction | BICRAL interactions | 5.65e-05 | 43 | 35 | 3 | int:BICRAL | |
| Interaction | LUC7L interactions | 5.79e-05 | 242 | 35 | 5 | int:LUC7L | |
| Interaction | GATAD2B interactions | 6.14e-05 | 245 | 35 | 5 | int:GATAD2B | |
| Interaction | CDC16 interactions | 6.26e-05 | 246 | 35 | 5 | int:CDC16 | |
| Interaction | SMARCA5 interactions | 7.20e-05 | 415 | 35 | 6 | int:SMARCA5 | |
| Interaction | SRSF7 interactions | 8.21e-05 | 425 | 35 | 6 | int:SRSF7 | |
| Interaction | RNPS1 interactions | 8.21e-05 | 425 | 35 | 6 | int:RNPS1 | |
| Interaction | MAPKAPK2 interactions | 8.34e-05 | 134 | 35 | 4 | int:MAPKAPK2 | |
| Interaction | ESRRB interactions | 8.43e-05 | 262 | 35 | 5 | int:ESRRB | |
| Interaction | MTA2 interactions | 9.33e-05 | 435 | 35 | 6 | int:MTA2 | |
| Interaction | NAF1 interactions | 9.35e-05 | 138 | 35 | 4 | int:NAF1 | |
| Interaction | PHF10 interactions | 9.61e-05 | 139 | 35 | 4 | int:PHF10 | |
| Interaction | NKX3-1 interactions | 1.00e-04 | 52 | 35 | 3 | int:NKX3-1 | |
| Interaction | THRAP3 interactions | 1.03e-04 | 443 | 35 | 6 | int:THRAP3 | |
| Interaction | CBX3 interactions | 1.04e-04 | 646 | 35 | 7 | int:CBX3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p14 | 6.49e-04 | 49 | 35 | 2 | chr10p14 | |
| GeneFamily | PHD finger proteins | 1.72e-04 | 90 | 22 | 3 | 88 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.88e-03 | 53 | 22 | 2 | 532 | |
| Coexpression | UDAYAKUMAR_MED1_TARGETS_UP | 1.00e-06 | 136 | 35 | 5 | M3909 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.33e-06 | 856 | 35 | 9 | M4500 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 3.09e-06 | 171 | 35 | 5 | M5655 | |
| Coexpression | PGF_UP.V1_UP | 5.17e-06 | 190 | 35 | 5 | M2674 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.36e-05 | 610 | 35 | 7 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 1.44e-05 | 615 | 35 | 7 | M8673 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 1.52e-05 | 408 | 35 | 6 | M11891 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 1.67e-05 | 415 | 35 | 6 | MM1028 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 2.05e-05 | 650 | 35 | 7 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 2.24e-05 | 659 | 35 | 7 | MM1040 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 2.74e-05 | 680 | 35 | 7 | M41089 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 2.92e-05 | 272 | 35 | 5 | M15123 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 3.52e-05 | 474 | 35 | 6 | M40991 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 6.66e-05 | 1394 | 35 | 9 | M9585 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 7.64e-05 | 170 | 35 | 4 | M5657 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP | 9.42e-05 | 66 | 35 | 3 | M1752 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | 1.40e-04 | 199 | 35 | 4 | M3328 | |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN | 1.40e-04 | 199 | 35 | 4 | M5799 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | 1.58e-04 | 389 | 35 | 5 | M6520 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 1.61e-04 | 79 | 35 | 3 | M7102 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 2.10e-04 | 656 | 35 | 6 | M18979 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 2.18e-04 | 417 | 35 | 5 | M39224 | |
| Coexpression | FISCHER_DREAM_TARGETS | 2.51e-04 | 969 | 35 | 7 | M149 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 2.57e-04 | 432 | 35 | 5 | M41149 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 3.63e-04 | 466 | 35 | 5 | M13522 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 5.24e-04 | 118 | 35 | 3 | M15305 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 5.66e-04 | 790 | 35 | 6 | M12490 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | RABL6 SREK1 CDC5L AKAP9 THOC2 UPF2 TCERG1 RBBP6 PHF3 INTS13 TOP1 RSRC1 BRD7 | 2.97e-08 | 1257 | 34 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | RABL6 SREK1 CDC5L AKAP9 THOC2 UPF2 TCERG1 RBBP6 PHF3 INTS13 TOP1 RSRC1 BRD7 | 1.71e-07 | 1459 | 34 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.57e-07 | 186 | 34 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 5.03e-06 | 843 | 34 | 9 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 4.36e-05 | 844 | 34 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.19e-05 | 629 | 34 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.41e-05 | 259 | 34 | 5 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.94e-05 | 469 | 34 | 6 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 9.41e-05 | 150 | 34 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 1.16e-04 | 492 | 34 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 1.18e-04 | 493 | 34 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 1.27e-04 | 983 | 34 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.64e-04 | 524 | 34 | 6 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.78e-04 | 532 | 34 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.43e-04 | 192 | 34 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.44e-04 | 564 | 34 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_100 | 2.58e-04 | 15 | 34 | 2 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 2.68e-04 | 819 | 34 | 7 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | 2.68e-04 | 819 | 34 | 7 | gudmap_developingGonad_e16.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | 2.74e-04 | 822 | 34 | 7 | gudmap_developingGonad_e14.5_ testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.92e-04 | 831 | 34 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.17e-04 | 378 | 34 | 5 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | e10.5_NeuroEpith_CentrlOverEmin_top-relative-expression-ranked_500_2 | 3.24e-04 | 207 | 34 | 4 | Facebase_ST1_e10.5_NeuroEpith_CentrlOverEmin_500_2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.25e-04 | 595 | 34 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | e9.5_MaxilArch_top-relative-expression-ranked_250 | 3.74e-04 | 215 | 34 | 4 | Facebase_ST1_e9.5_MaxilArch_250 | |
| CoexpressionAtlas | e9.5_MaxilArch_top-relative-expression-ranked_100 | 3.75e-04 | 88 | 34 | 3 | Facebase_ST1_e9.5_MaxilArch_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 4.25e-04 | 403 | 34 | 5 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.44e-04 | 225 | 34 | 4 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.98e-04 | 232 | 34 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.64e-04 | 429 | 34 | 5 | gudmap_developingGonad_e14.5_ testes_1000_k5 | |
| CoexpressionAtlas | e10.5_Emin_MedialNasal_top-relative-expression-ranked_500_3 | 5.65e-04 | 240 | 34 | 4 | Facebase_ST1_e10.5_Emin_MedialNasal_500_3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 6.17e-04 | 1241 | 34 | 8 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | e9.5_MaxilArch_top-relative-expression-ranked_500 | 6.26e-04 | 439 | 34 | 5 | Facebase_ST1_e9.5_MaxilArch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 6.54e-04 | 1252 | 34 | 8 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | e9.5_MandibArch_top-relative-expression-ranked_500 | 7.44e-04 | 456 | 34 | 5 | Facebase_ST1_e9.5_MandibArch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 7.77e-04 | 978 | 34 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 8.30e-04 | 989 | 34 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.90e-04 | 271 | 34 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 1.02e-03 | 124 | 34 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.10e-03 | 498 | 34 | 5 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 1.10e-03 | 498 | 34 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.48e-03 | 311 | 34 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.49e-03 | 533 | 34 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.59e-03 | 806 | 34 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.68e-03 | 815 | 34 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.70e-03 | 323 | 34 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.80e-03 | 328 | 34 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 1.84e-03 | 1468 | 34 | 8 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 2.15e-03 | 161 | 34 | 3 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_500 | 2.39e-03 | 167 | 34 | 3 | gudmap_developingGonad_e16.5_testes_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 2.60e-03 | 172 | 34 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.77e-03 | 176 | 34 | 3 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k2_1000 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.68e-10 | 197 | 35 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-07 | 187 | 35 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 4.14e-07 | 194 | 35 | 5 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 4.35e-07 | 196 | 35 | 5 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.81e-07 | 200 | 35 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.81e-07 | 200 | 35 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.40e-05 | 188 | 35 | 4 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.52e-05 | 192 | 35 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.55e-05 | 193 | 35 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.55e-05 | 193 | 35 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.71e-05 | 198 | 35 | 4 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.71e-05 | 198 | 35 | 4 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.75e-05 | 199 | 35 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.75e-05 | 199 | 35 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.72e-04 | 138 | 35 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.11e-04 | 148 | 35 | 3 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | LAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class | 2.71e-04 | 161 | 35 | 3 | bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.96e-04 | 166 | 35 | 3 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 3.01e-04 | 167 | 35 | 3 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 167 | 35 | 3 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 180 | 35 | 3 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 180 | 35 | 3 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 182 | 35 | 3 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 182 | 35 | 3 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 182 | 35 | 3 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.13e-04 | 186 | 35 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.13e-04 | 186 | 35 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 188 | 35 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.39e-04 | 190 | 35 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-04 | 190 | 35 | 3 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.53e-04 | 192 | 35 | 3 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.53e-04 | 192 | 35 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | 44ba79db566d0fa3bbcfe3adf9164bf8c3cb0bc3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.60e-04 | 193 | 35 | 3 | e477f5ddbb9d5878560998250ca0e1a5467953f4 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | f92bbe70e6c725bfb8c08bfc2a94e375528151a3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.67e-04 | 194 | 35 | 3 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.67e-04 | 194 | 35 | 3 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-04 | 194 | 35 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.81e-04 | 196 | 35 | 3 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.88e-04 | 197 | 35 | 3 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.88e-04 | 197 | 35 | 3 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.88e-04 | 197 | 35 | 3 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.88e-04 | 197 | 35 | 3 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.88e-04 | 197 | 35 | 3 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 4.95e-04 | 198 | 35 | 3 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.95e-04 | 198 | 35 | 3 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.95e-04 | 198 | 35 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-04 | 199 | 35 | 3 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.03e-04 | 199 | 35 | 3 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.03e-04 | 199 | 35 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.03e-04 | 199 | 35 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.03e-04 | 199 | 35 | 3 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.10e-04 | 200 | 35 | 3 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 5.10e-04 | 200 | 35 | 3 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.10e-04 | 200 | 35 | 3 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 5.10e-04 | 200 | 35 | 3 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.10e-04 | 200 | 35 | 3 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.10e-04 | 200 | 35 | 3 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| Computational | Genes in the cancer module 36. | 3.04e-05 | 162 | 25 | 5 | MODULE_36 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.87e-09 | 177 | 34 | 7 | 985_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 6.39e-06 | 178 | 34 | 5 | 3998_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.47e-06 | 193 | 34 | 5 | 3906_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HG-U133A | 1.02e-05 | 196 | 34 | 5 | 1906_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.14e-04 | 169 | 34 | 4 | 5231_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.28e-04 | 174 | 34 | 4 | 1302_UP | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.42e-04 | 179 | 34 | 4 | 4585_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.69e-04 | 187 | 34 | 4 | 4302_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.76e-04 | 189 | 34 | 4 | 5084_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.76e-04 | 189 | 34 | 4 | 1045_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.83e-04 | 191 | 34 | 4 | 1008_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.86e-04 | 192 | 34 | 4 | 5058_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 1.86e-04 | 192 | 34 | 4 | 2101_DN | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 1.86e-04 | 192 | 34 | 4 | 7065_DN | |
| Drug | oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA | 1.94e-04 | 194 | 34 | 4 | 971_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; HL60; HG-U133A | 1.98e-04 | 195 | 34 | 4 | 2006_DN | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4549_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 5290_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 6937_DN | |
| Drug | Dirithromycin [62013-04-1]; Up 200; 4.8uM; HL60; HG-U133A | 2.10e-04 | 198 | 34 | 4 | 1712_UP | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; HL60; HG-U133A | 2.10e-04 | 198 | 34 | 4 | 1407_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 1825_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 2123_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 7020_UP | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 1469_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 4817_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.18e-04 | 200 | 34 | 4 | 2061_DN | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.34e-05 | 195 | 34 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 4.44e-04 | 27 | 34 | 2 | C0036920 | |
| Disease | Mental Retardation, Psychosocial | 5.50e-04 | 139 | 34 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 5.50e-04 | 139 | 34 | 3 | C0020796 | |
| Disease | Mental deficiency | 5.50e-04 | 139 | 34 | 3 | C0917816 | |
| Disease | Intellectual Disability | 1.68e-03 | 447 | 34 | 4 | C3714756 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.17e-03 | 224 | 34 | 3 | EFO_0004574, EFO_0008317 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.88e-03 | 69 | 34 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | chin morphology measurement | 2.96e-03 | 70 | 34 | 2 | EFO_0007842 | |
| Disease | cancer (implicated_via_orthology) | 3.60e-03 | 268 | 34 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | Cleft Palate | 3.94e-03 | 81 | 34 | 2 | C0008925 | |
| Disease | lipid measurement, lipoprotein measurement | 4.84e-03 | 90 | 34 | 2 | EFO_0004529, EFO_0004732 | |
| Disease | osteoarthritis, hip | 5.06e-03 | 92 | 34 | 2 | EFO_1000786 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 5.49e-03 | 96 | 34 | 2 | EFO_0004529, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 5.83e-03 | 99 | 34 | 2 | EFO_0004639, EFO_0008595 | |
| Disease | remnant cholesterol measurement | 6.90e-03 | 108 | 34 | 2 | EFO_0010815 | |
| Disease | free cholesterol measurement | 7.53e-03 | 113 | 34 | 2 | EFO_0008591 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGNEKKQREKEKKRS | 2651 | Q99996 | |
| KRRKKSAGERLKEEK | 501 | Q9HCK8 | |
| LRSEKEGRDRKKDKQ | 251 | Q99459 | |
| EGRDRKKDKQHLKRK | 256 | Q99459 | |
| EEKGRKRRRVKEDKK | 76 | Q9NPI1 | |
| DDEERRKRKEEKKRK | 81 | Q9H8M2 | |
| RREKREKDEKEKAEK | 386 | Q13111 | |
| RNDRNKKKKEVKEEG | 161 | P13631 | |
| KKSKDKEEGKEERRR | 676 | Q3YEC7 | |
| KKRGRKREDKEDKSE | 571 | Q9NVM9 | |
| EKSKRDREKDKKRAD | 486 | Q6GQQ9 | |
| ERKELKKDEGRKEEK | 426 | P78559 | |
| KRKAEKEKSNKEREG | 331 | Q96T17 | |
| DDDDPDKDKKRQKKR | 266 | O14770 | |
| RRKSKRGKKEAEDEL | 236 | P36776 | |
| KKNEKREIKGDEEKR | 266 | Q86XE3 | |
| DNKGEKRKRKTEEKG | 1141 | Q7Z6E9 | |
| RRRFKKKDAVKDKEE | 171 | Q12948 | |
| EKKKGAEEEKPKRRR | 296 | A8MPP1 | |
| DNEESEKRRKKKKGT | 236 | Q3T8J9 | |
| RKKDRKKQRPADAED | 441 | Q8N6R0 | |
| DRDRDRDKDRDKKKS | 1511 | Q15648 | |
| KAPEDKKKRLEDDKR | 51 | Q9HAU5 | |
| GKRKEKDKERREKRD | 546 | A8MW92 | |
| ERKKKEDGKRARADK | 166 | P13984 | |
| DKREKEKVKDKGRED | 631 | Q5VWG9 | |
| RRKEEGEEKKGKKIK | 841 | Q86T75 | |
| RDKDDESKKQKKRGR | 1431 | P51532 | |
| EKEREKEKERGKNKD | 286 | Q8WXA9 | |
| KEKERGKNKDRDKER | 291 | Q8WXA9 | |
| GKNKDRDKEREKDRE | 296 | Q8WXA9 | |
| RDKEREKDREKDKEK | 301 | Q8WXA9 | |
| SRNKKDKKREKERDH | 411 | Q8WXA9 | |
| ERLREEKKAEKKGKE | 951 | Q6Q759 | |
| EKKDEKDRKERKRDH | 1471 | Q8NI27 | |
| KKRKRDDNKDIDSEK | 626 | O14776 | |
| KDKEREKSKHREGEK | 2006 | Q92576 | |
| GRDKEKREKEKDKGK | 141 | Q96IZ7 | |
| HKDRDKEKRKEEKVR | 81 | P11387 | |
| NKNRDKGEKEKKRDS | 1806 | P18583 |